Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2015 Dec 2:15:113.
doi: 10.1186/s12905-015-0270-6.

Effectiveness of a low dose testosterone undecanoate to improve sexual function in postmenopausal women

Reuthairat Tungmunsakulchai  1 , Sukanya Chaikittisilpa  2 , Thiti Snabboon  3 , Krasean Panyakhamlerd  4 , Unnop Jaisamrarn  5 , Nimit Taechakraichana  6
Affiliations
Randomized Controlled Trial

Effectiveness of a low dose testosterone undecanoate to improve sexual function in postmenopausal women

Reuthairat Tungmunsakulchai et al. BMC Womens Health. .

Abstract

Background: Adding testosterone to hormonal therapy could improve sexual function and general well-being among women during climacteric. We evaluated the effectiveness of testosterone undecanoate on sexual function in postmenopausal women utilizing the standardized questionnaire FSFI score.

Methods: Postmenopausal women with sexual complaints and Female Sexual Function Index (FSFI) ≤ 26.5 were enrolled in to this randomized, double-blinded, placebo-controlled trial. Participants were randomly assigned to 8-week treatment with either oral testosterone undecanoate 40 mg or placebo twice weekly with daily oral estrogen. The FSFI scores before and after treatment were compared to assess any improvement of sexual function.

Results: Seventy women were recruited of which each group had 35 participants. The baseline characteristics and baseline FSFI scores were comparable between both groups. After 8 weeks of treatment, the FSFI scores significantly improved in both groups when compared to the baseline but the FSFI scores from the testosterone group were significantly higher than in the placebo group post-treatment (28.6 ± 3.6, 25.3 ± 6.7, respectively, p = 0.04). There was no difference in adverse effect between the two groups

Conclusions: The twice weekly addition of testosterone undecanoate to daily oral estrogen was associated with a significant improvement in sexual function among postmenopausal women than the use of the estrogen alone.

Trial registration: ClinicalTrials.gov Identifier NCT01724658 (February 17, 2012).

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Flow diagram of study, based on CONSORT guidelines 2010
See this image and copyright information in PMC

References

    1. Peeyananjarassri K, Liabsuetrakul T, Soonthornpun K, Choobun T, Manopsilp P. Sexual functioning in postmenopausal women not taking hormone therapy in the Gynecological and Menopause Clinic, Songklanagarind Hospital measured by female sexual function index questionaire. J Med Assoc Thai. 2008;91:625–32. - PubMed
    1. Schwenkhagen A, Studd J. Role of testosterone in the treatment of hypoactive sexual desire disorder. Maturitas. 2009;63:152–9. doi: 10.1016/j.maturitas.2009.02.011. - DOI - PubMed
    1. Anita HC. The pathophysiology of hypoactive sexual desire disorder in women. Inter J Gynecol Obstet. 2010;110:7–11. doi: 10.1016/j.ijgo.2010.02.014. - DOI - PubMed
    1. Shifren JL, Glenn DB, James AS, Peter RC, John EB, Geoffrey PR, et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med. 2000;343:682–8. doi: 10.1056/NEJM200009073431002. - DOI - PubMed
    1. The North American Menopause Society . The Role of Testosterone Therapy in Postmenopausal Women: Position Statement of The North American Menopause Society. USA: The North American Menopause Society; 2005. - PubMed

Publication types

Associated data